ID   FGFR2_CHICK             Reviewed;         823 AA.
AC   P18461;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   02-DEC-2020, entry version 165.
DE   RecName: Full=Fibroblast growth factor receptor 2;
DE            Short=FGFR-2;
DE            EC=2.7.10.1;
DE   AltName: Full=Tyrosine kinase receptor CEK3;
DE   Flags: Precursor;
GN   Name=FGFR2; Synonyms=CEK3;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2165604; DOI=10.1073/pnas.87.15.5812;
RA   Pasquale E.B.;
RT   "A distinctive family of embryonic protein-tyrosine kinase receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:5812-5816(1990).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor
CC       for fibroblast growth factors and plays an essential role in the
CC       regulation of cell proliferation, differentiation, migration and
CC       apoptosis, and in the regulation of embryonic development. Required for
CC       normal embryonic patterning, limb bud development, lung morphogenesis,
CC       osteogenesis and skin development. Plays an essential role in the
CC       regulation of osteoblast differentiation, proliferation and apoptosis,
CC       and is required for normal skeleton development. Promotes cell
CC       proliferation in keratinocytes and immature osteoblasts, but promotes
CC       apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and
CC       PAK4. Ligand binding leads to the activation of several signaling
CC       cascades. Activation of PLCG1 leads to the production of the cellular
CC       signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate.
CC       Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and
CC       SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the
CC       MAP kinase signaling pathway, as well as of the AKT1 signaling pathway.
CC       FGFR2 signaling is down-regulated by ubiquitination, internalization
CC       and degradation. Mutations that lead to constitutive kinase activation
CC       or impair normal FGFR2 maturation, internalization and degradation lead
CC       to aberrant signaling. Over-expressed FGFR2 promotes activation of
CC       STAT1 (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence
CC       of bound ligand. Ligand binding leads to dimerization and activation by
CC       autophosphorylation on tyrosine residues (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Homodimer after ligand binding (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Golgi apparatus {ECO:0000250}. Cytoplasmic vesicle
CC       {ECO:0000250}. Note=Detected on osteoblast plasma membrane lipid rafts.
CC       After ligand binding, the activated receptor is rapidly internalized
CC       and degraded (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The second and third Ig-like domains directly interact with
CC       fibroblast growth factors (FGF) and heparan sulfate proteoglycans.
CC       {ECO:0000250}.
CC   -!- PTM: Autophosphorylated. Binding of FGF family members together with
CC       heparan sulfate proteoglycan or heparin promotes receptor dimerization
CC       and autophosphorylation on tyrosine residues. Autophosphorylation
CC       occurs in trans between the two FGFR molecules present in the dimer (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: N-glycosylated in the endoplasmic reticulum. The N-glycan chains
CC       undergo further maturation to an Endo H-resistant form in the Golgi
CC       apparatus (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. FGFR2 is rapidly ubiquitinated after
CC       autophosphorylation, leading to internalization and degradation.
CC       Subject to degradation both in lysosomes and by the proteasome (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Fibroblast growth factor receptor subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M35196; AAA48665.1; -; mRNA.
DR   PIR; B35963; B35963.
DR   RefSeq; NP_990650.1; NM_205319.2.
DR   SMR; P18461; -.
DR   STRING; 9031.ENSGALP00000037940; -.
DR   PaxDb; P18461; -.
DR   Ensembl; ENSGALT00000038732; ENSGALP00000037940; ENSGALG00000009495.
DR   GeneID; 396259; -.
DR   KEGG; gga:396259; -.
DR   CTD; 2263; -.
DR   eggNOG; KOG0200; Eukaryota.
DR   GeneTree; ENSGT00940000155447; -.
DR   HOGENOM; CLU_000288_74_3_1; -.
DR   InParanoid; P18461; -.
DR   OrthoDB; 220433at2759; -.
DR   BRENDA; 2.7.10.1; 1306.
DR   PRO; PR:P18461; -.
DR   Proteomes; UP000000539; Chromosome 6.
DR   Bgee; ENSGALG00000009495; Expressed in female gonad and 11 other tissues.
DR   ExpressionAtlas; P18461; baseline and differential.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0017134; F:fibroblast growth factor binding; IBA:GO_Central.
DR   GO; GO:0005007; F:fibroblast growth factor-activated receptor activity; IBA:GO_Central.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:InterPro.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR016248; FGF_rcpt_fam.
DR   InterPro; IPR041159; FGFR_TM.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF18123; FGFR3_TM; 1.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF000628; FGFR; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   Apoptosis; ATP-binding; Cell membrane; Cytoplasmic vesicle; Disulfide bond;
KW   Glycoprotein; Golgi apparatus; Immunoglobulin domain; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..823
FT                   /note="Fibroblast growth factor receptor 2"
FT                   /id="PRO_0000016791"
FT   TOPO_DOM        24..379
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        380..400
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        401..823
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..128
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          156..249
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          258..360
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          483..772
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         489..497
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         567..569
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          163..180
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        135..145
FT                   /note="Asp/Glu-rich (highly acidic)"
FT   ACT_SITE        628
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         519
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         573
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         468
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         588
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         658
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         659
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         771
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        86
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        126
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        148
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        230
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        243
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        267
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        299
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        320
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        333
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        65..110
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        181..233
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        280..344
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   823 AA;  92299 MW;  42BF3CC4EA02FD43 CRC64;
     MVSWDSGCLI CLVVVTMAGL SLARPSFNLV VEDATLEPEE PPTKYQISQP DVHSALPGEP
     LELRCQLKDA VMISWTKDGV PLGPDNRTVI IGEYLQIKDA SPRDSGLYAC TAIRTLDSDT
     LYFIVNVTDA LSSGDDEDDN DGSEDFVNDS NQMRAPYWTH TDKMEKRLHA VPAANTVKFR
     CPAMGNPTPT MRWLKNGKEF KQEHRIGGYK VRNQHWSLIM ESVVPSDKGN YTCIVENQYG
     SINHTYHLDV VERSPHRPIL QAGLPANASA VVGGDVEFVC KVYSDAQPHI QWIKHVERNG
     SKYGPDGLPY LQVLKAAGVN TTDKEIEVLY IRNVTFEDAG EYTCLAGNSI GISFHTAWLT
     VLPAPEKEKE FPTSPDYLEI AIYCIGVFLI ACMVLTVILC RMKNTTKKPD FSSQPAVHKL
     TKRIPLRRQV TVSADSSSSM NSNTPLVRIT TRLSSTADAP MLAGVSEYEL PEDPKWEFPR
     DKLTLGKPLG EGCFGQVVMA EAVGIDKDRP KEAVTVAVKM LKDDATEKDL SDLVSEMEMM
     KMIGKHKNII NLLGACTQDG PLYVIVEYAS KGNLREYLRA RRPPGMEYSF DINRVPEEQM
     TFKDLVSCTY QLARGMEYLA SQKCIHRDLA ARNVLVTENN VMKIADFGLA RDINNIDYYK
     KTTNGRLPVK WMAPEALFDR VYTHQSDVWS FGVLMWEIFT LGGSPYPGIP VEELFKLLKE
     GHRMDKPANC TNELYMMMRD CWQAVPSQRP TFKQLVEDLD RILTLTTNEE YLDLSGPLEQ
     YSPSYPDTRS SCSSGDDSVF SPDPMPYEPC LPKYQHMNGS VKT
//
